01/21/2019 / By Ralph Flores
A study published in the American Journal of Physiology-Cell Physiology has found that chemotherapy can cause adverse effects on the skeletal muscle of patients undergoing treatment. In the study, researchers from the University of Vermont looked at whether chemotherapeutics for breast cancer impact skeletal muscle structure and protein expression.
Researchers concluded that chemotherapy can negatively affect skeletal muscle in patients undergoing therapy.
Learn more about the negative effects of chemotherapy at Chemotherapy.news.
Journal Reference:
Guigni BA, Callahan DM, Tourville TW, Miller MS, Fiske B, Voigt T, Korwin-Mihavics B, Anathy V, Dittus K, Toth MJ. Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress. American Journal of Physiology-Cell Physiology. November 2018;315(5). DOI: 10.1152/ajpcell.00002.2018
Tagged Under: cancer treatments, cancer tumors, doxorubicin, Oncology, paclitaxel, poison, poisons, toxins